Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Dexmethylphenidate hydrochloride by Cingulate for Attention Deficit Hyperactivity Disorder (ADHD): Likelihood of Approval
Dexmethylphenidate hydrochloride is under clinical development by Cingulate and currently in Phase III for Attention Deficit Hyperactivity Disorder (ADHD). According...
Data Insights
Dexmethylphenidate hydrochloride by Cingulate for Attention Deficit Hyperactivity Disorder (ADHD): Likelihood of Approval
Dexmethylphenidate hydrochloride is under clinical development by Cingulate and currently in Phase III for Attention Deficit Hyperactivity Disorder (ADHD). According...